IQVIA
Update in progressIQV (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
IQVIA Holdings provides clinical research services, commercial insights, and healthcare intelligence to life sciences and healthcare companies worldwide. It has three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. It offers cloud-based tools, real-world evidence, analytics, trial management, lab services, and medical/scientific support for pharma, biotech, devices, and consumer health. Based in Durham, NC.
Company score
- Sentiment
- 0.82
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.46
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.48
- Governance
- 0.20
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.34
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.58
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited States
- CEOMr. Ari Bousbib
- Employees94,000
- Websitewww.iqvia.com
Identifiers
- ISINUS46266C1053
- FIGIBBG00333FYS2
- LEI549300W3R20NM4KQPH86
- CUSIP46266C105
- CIK0001478242